IDEXX Laboratories shares are trading lower after the company reported a Q3 revenue miss and issued guidance below estimates.
Portfolio Pulse from Benzinga Newsdesk
IDEXX Laboratories shares declined following a Q3 revenue miss and guidance below estimates.
October 31, 2024 | 1:28 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
IDEXX Laboratories reported a Q3 revenue miss and issued guidance below estimates, leading to a decline in share price.
The company's Q3 revenue miss and lower guidance are negative indicators for investors, likely causing a short-term decline in stock price as market expectations were not met.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100